405
Views
4
CrossRef citations to date
0
Altmetric
Hemoglobinopathy: Current Clinical Practice

The expanding spectrum of thalassemia intermedia

, &
Pages 311-314 | Published online: 18 Jul 2013

References

  • Thein SL. ²-Thalassemia. In: Higgs DR, Weatherall DJ. (eds) The haemoglobinopathies. Bailhere's Clin Haematol 1993; 6: 151–175.
  • Tamagnini GP, Lopes MC, Castanheira ME, Wainscoat JS. )3+ thalassemia Portuguese type: clinical, haematological and molecular studies of a newly defined form of )3-thalassemia. Br J Haematol 1983; 54: 189–200.
  • Diaz-Chico JC, Yang KG, Stoming TA. Mild and severe fl-thalassemia among homozygotes from Turkey: identification of the types by hybridization of amplified DNA with synthetic probes. Blood 1988; 71: 248–253.
  • Rosatelli MC, Oggiano L, Leoni GB et al. Thalassemia intermediaresulting from a mild fl-thalassemia mutation. Blood 1989; 73: 601–605.
  • Meloni A, Rosatelli MC, Fa.à. V et al. Promoter mutations producing mild fl-thalassemia in the Italian population. Br J Haematol 1992; 80: 222–226.
  • Adekile A, Haider M, Kutlar F. Mutations Associated with Beta-Thalassemia intermedia in Kuwait. Med Princ Pract 2005; 14: 69–72.
  • Neishabury M, Azarkeivan A, Oberkanins C, Esteghamat F, Amirizadeh N, Najmabadi H. Molecular mechanisms underlying thalassemia intermedia in Iran. Genetic Testing 2008; 12(4): 549–556.
  • Oner R, Oner C, Birben E, Sözen M, Giimriik F, Giirgey A, Altay C. beta-Thalassaemia intermedia in a Turkish girl: homozygosity for G-->A substitution at + 22 relative to the beta-globin cap site. Br J Haematol 2001; 115: 90–94.
  • Chen XW, Mo QH, Li Q, Zeng R, Xu XM. A novel mutation of -73(A-->T) in the CCAAT box of the beta-globin gene identified in a patient with the mild beta-thalassemia intermedia. Ann Hematol 2007; 86(9): 653–657.
  • Panigrahi I, Agarwal S, Pradhan M, Choudhry DR, Choudhry VP, Saxena R. Molecular characterization of thalassemia intermedia in Indians. Haematologica 2006; 91: 1279–1280.
  • Nadkarni A, Gorakshakar AC, Lu CY, Krishnamoorthy R, Ghosh K, Colah R, Mohanty D 2001. Molecular pathogenesis and clinical variability of fl-thalassemia syndromes among Indians. Am J Hematol 2001; 68: 75–80.
  • Tan Jin Ai MA, Yap SF, Tan KL, Wong YC, Wee YC, Kok JL. Mild beta-thalassemia intermedia caused by compound hetero-zygosity for (G)gamma((A)gammadeltabeta)(o)/beta-thalassemia and molecular characterization of the defect in four Chinese families. Acta Haematol 2003; 109: 169–175.
  • Karimi M, Yarmohammadi H, Farjadian S, Zeinali S, Moghaddam Z, Cappellini MD, Giordano PC. Beta-thalassemia intermedia from southern Iran: IVS-II-1 (G-->A) is the prevalent thalassemia intermedia allele. Hemoglobin 2002; 26: 147–154.
  • Haghi M, Feizi AA, Harteveld CL, Pouladi N, Feizi MA. Homozygosity for a rare beta 0-thalassemia mutation [frameshift codons 25/26 (+T)] causes beta-thalassemia intermedia in an Iranian family. Hemoglobin 2009; 33: 75–80.
  • Verma IC, Kleanthous M, Saxena R et al. Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations. Hemoglobin 2007; 31(4): 439–452.
  • Fucharoen S, Fucharoen G, Sanchaisuriya K, Surapot S. Molecular characterization of thalassemia intermedia associated with HPFH-6/beta-thalassemia and HPFH-6/Hb E in Thai patients. Acta Haematol 2002; 108(3): 157–161.
  • Fucharoen S, Pengjam Y, Surapot S, Fucharoen G, Sanchaisuriya K. Molecular and hematological characterization of HPFH-6/ Indian deletion-inversion Ggamma(Agammadeltabeta)0-thalasse-mia and Ggamma(Agammadeltabeta)0-thalassemia/HbE in Thai patients. Am J Hematol 2002; 71(2): 109–113.
  • Chang YP, Littera R, Garau R et al. The role of heterocellular hereditary persistence of fetal haemoglobin in beta(0)-thalassaemia intermedia. Br J Haematol 2001; 114(4): 899–906.
  • Qu G, Elkins S, Steinberg MH. Thalassemia intermedia and extramedullary hematopoiesis associated with compound hetero-zygosity for the 532 bp deletion of the beta-globin gene and gene deletion hereditary persistence of fetal hemoglobin. Hemoglobin 2001; 25(1): 91–96.
  • Li Z, Liu L, Zhao Y, Zhong X, Xu X. Two thalassemia intermedia patients with delta beta/beta thalassemia and a deletional type alpha-thalassemia. Haematologica 2001; 86(1): 108.
  • Shaji RV, Edison ES, Krishnamoorthy R, Chandy M, Srivastava A. Hb Lepore in the Indian population. Hemoglobin 2003; 27(1): 7–14.
  • So CC, Chan AY, Tsang ST et al. A novel beta-delta globin gene fusion, anti-Lepore Hong Kong, leads to overexpression of delta globin chain and a mild thalassaemia intermedia phenotype when co-inherited with beta(0)-thalassaemia. Br J Haematol 2007; 136: 158–162.
  • Camaschella C, Mazza U, Roetto A et al. Genetic interactions in thalassemia intermedia: analysis of beta-mutations, alpha-geno-type, gamma-promoters, and beta-LCR hypersensitive sites 2 and 4 in Italian patients. Am J Hematol 1995; 48: 82–87.
  • Premawardhena A, Fisher CA, Olivieri NF et al. A novel molecular basis for beta thalassemia intermedia poses new questions about its pathophysiology. Blood 2005; 106(9): 3251–3255.
  • Efremov GD. Dominantly inherited beta-thalassemia. Hemoglobin 2007; 31(2): 193–207.
  • Faustino P, Osório-Almeida L, Romdo L et al. Dominantly transmitted beta-thalassemia arising from the production of several aberrant mRNA species and one abnormal peptide. Blood 1998; 91(2): 685–690.
  • Weinstein BI, Erramouspe B, Albuquerque DM et al. Hb Florida: a novel elongated C-terminal beta-globin variant causing dominant beta-thalassemia phenotype. Am J Hematol 2006; 81(5): 358–360.
  • Luo HY, Tang W, Eung SH et al. Dominantly inherited beta thalassaemia intermedia caused by a new single nucleotide deletion in exon 2 of the beta globin gene: Hb Morgantown (beta91 CTG>CG). J Clin Pathol 2005; 58(10): 1110–1112.
  • Gray GR, Manson HE, Gu LH, Leonova JYe, Huisman TH. Hb Lulu Island (alpha 2 beta 2 107[G9]Gly-->Asp)-beta zero thalassemia (codon 15; TGG-->TAG), a form of thalassemia intermedia. Am J Hematol 1995; 50(1): 26–29.
  • Badens C, Mattei MG, Imbert AM et al. A novel mechanism for thalassaemia intermedia. Lancet 2002; 12: 132–133.
  • Galanello R, Perseu L, Perra C et al. Somatic deletion of the normal beta-globin gene leading to thalassaemia intermedia in heterozygous beta-thalassaemic patients. Br J Haematol 2004; 127(5): 604–606.
  • Wajcman H, Traeger-Synodinos J, Papassotiriou I et al. Unstable and thalassemic alpha chain hemoglobin variants: a cause of Hb H disease and thalassemia intermedia. Hemoglobin 2008; 32(4): 327–349.
  • Fucharoen S, Fucharoen G, Sae-ung N, Sanchaisuriya K. Thalassemia intermedia associated with the Hb Constant Spring EE Bart's disease in pregnancy: a molecular and hematological analysis. Blood Cells Mol Dis 2007; 39(2): 195–198.
  • Stamoulakatou A, Athanasiou-Metaxa M, Traeger-Synodinos J et al. Rare thalassemic syndrome caused by interaction of Hb Questembert (alpha! codon 131, TCT>CCT, Ser>Pro) with an alpha-thalassemia-2 deletion: implications for diagnosis and management. Blood Cells Mol Dis 2004; 32(1): 118–123.
  • Efremov GD, Simjanovska L, Plaseska-Karanfilska D, Stanojevic E, Petkov GH. Hb Jambol: a new hyperunstable hemoglobin causing severe hemolytic anemia. Acta Haematol 2007; 117: 1–7.
  • Sura T, Busabaratana M, Youngcharoen S, Wisedpanichkij R, Viprakasit V, Trachoo O. Haemoglobin Hope in a northern Thai family: first identification of homozygous haemoglobin Hope associated with haemoglobin H disease. Eur J Haematol 2007; 79: 251–254.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.